No significant rise in Cystatin C, serum creatinine or urinary [TIMP-2]*[IGFBP7] was observed in patients with AKI 0/1 at any time indicating that TAS with MHCA per se has no influence on the investigated G1 cell cycle arrest biomarkers or Cystatin C. This evidence concerns the gene CST3 and acute kidney injury.